the aid library

LIST OPTIONS

Filter

2380

Sort by:

Direction:

Download (960)

View PDF (1697)

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection, 12 September 2019

Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children AIDSinfo (2019) CC

Updated guidelines

Download (143)

View PDF (204)

An Evidence Review of Sexually Transmitted Infections in Humanitarian Settings

A. Silveira John Hopkins Bloomberg School of Public Health; ResearchGate (2019) C2

Accessed: 08.11.2020

Download (132)

View PDF (201)

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection - AIDSinfo

AIDSinfo (2019) C2

Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019 Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office of AIDS Research Advisory Council (OARAC)

Download (139)

View PDF (156)

HIV prevalence and determinants of loss-to- follow-up in adolescents and young adults with tuberculosis in Cape Town

P. Mulongeni; S. Hermans; J. Caldwell; et al. PLOS One (2019) CC

PLOS ONE | https://doi.org/10.1371/journal.pone.0210937 February 5, 2019

Download (125)

View PDF (190)

56o Conselho director - 70a sessão do comitê regional da OMS para as Américas

Organização Pan-Americana da Saúde; Organização Mundial da Saúde (Américas) (2018) C_WHO

Tema 8.22 da agenda provisória Washington, D.C., EUA, 23 a 27 de setembro de 2018 CD56/INF/22 31 de agosto de 2018 Original: inglês/espanhol

Download (221)

View PDF (128)

Standard treatment guidelines urology (India)

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr. 6, 2020

Download (62)

View PDF (843)

Optimizing HIV testing services in sub-Saharan Africa: cost and performance of verification testing with HIV self-tests and tests for triage

J. W. Eaton; F. Terris-Prestholt; V. Cambiano; et al. Journal of the International AIDS Society (2019) C2

Eaton JW et al. Journal of the International AIDS Society 2019, 22(S1):e25237 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25237/full | https://doi.org/10.1002/jia2.25237

Download (133)

View PDF (166)

Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A WHO practical toolkit

World Health Organization WHO (2019) C_WHO

Stewardship is defined as “the careful and responsible management of something entrusted to one’s care”. It was originally applied in the health-care setting as a tool for optimizing antimicrobial use, termed “antimicrobial stewardship” (AMS). Stewardship has since be... more

Download (122)

View PDF (120)

Effects of BCG on COVID-19 — based on information as of 25 December 2020

World Health Organization WHO (2020) C_WHO

WHO Regional Office for Africa

Download (91)

View PDF (127)

In this pandemic and panic of COVID-19 what should doctors know about masks and respirators?

Salvi, S.S. (2020) CC

Download (209)

View PDF (255)

Six concrete measures to support women and girls in all their diversity in the context of the COVID-19 pandemic

UNAIDS (2020) C_WHO

The report underscores that sexual and reproductive health and rights are often the first to be sacrificed during epidemics and that the gains of the past decade must be protected. The report also makes it clear that scarce resources must be focused on the most marginalized women and girls, includin... more

Download (94)

View PDF (128)

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK

European Centre for Disease Prevention and Control ECDC (2020) C_CDC

Download (85)

View PDF (136)

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol

European Centre for Disease Prevention and Control ECDC (2020) CC

This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th... more

Download (142)

View PDF (236)

Improving dietary intake and achieving food product improvement: Policy opportunities and challenges for the WHO European Region in reducing salt and sugar in the diet (2020)

World Health Organization WHOEurope (2020) C_WHO

This paper provides case studies of several food product improvement policies from across the WHO European Region. The aim is to share country experience, assess the various merits of the different approaches, discuss lessons learned, and provide guidance for best practice that may be more widely ap... more

Download (172)

View PDF (247)

Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans

Ojji, D.B.; et al. (2019) C1

N Engl J Med 2019;380:2429-39.DOI: 10.1056/NEJMoa1901113

Download (173)

View PDF (137)

Inequality monitoring in immunization: a step-by-step manual

World Health Organization WHO (2019) C_WHO

Download (3073)

View PDF (3106)

Standard Treatment Guidelines and Essential Medicines List for South Africa - Hospital Level Adults 2nd Edition - 2019

National Department of Health South Africa (2020) CC

The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th... more

Download (137)

View PDF (173)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Download (66)

View PDF (626)

A Is tuberculosis elimination a feasible goal in Colombia by 2050?

López, L.; Y. Keynan, D. Marin et al. (2019) CC

Health Policy and Planning, Volume 35, Issue 1, February 2020, Pages 47–57, https://doi.org/10.1093/heapol/czz122 Colombia has an underreporting of 30% of the total cases, according to World Health Organization (WHO) estimations. In 2016, successful tuberculosis (TB) treatment rate was 70%, and t... more

Download (84)

View PDF (94)

COVID-19: Implications for People with Chagas Disease

Zaidel, E.J.; et al. (2020) CC

Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.